Premium cannabis company Orchid Ventures, Inc. (CSE:ORCD, OTCPINK:ORVRF) (“Orchid” or the “Company”) and Pure Dispensaries, LLC mutually agreed to terminate the Stock Purchase Agreement to acquire 100% of the interest of Pure Dispensaries, LLC. The agreement was originally announced on October 8, 2019.

Corey Mangold, CEO of Orchid said, “Given the dynamic and ever changing landscape of the California Cannabis market, it has become more important for Orchid to carefully manage and invest its capital in strategic growth opportunities that are aligned with our business priorities. Our primary goal is to achieve profitability as quickly as possible. To be successful we must implement a more disciplined approach to our growth initiatives and diversification plans. We will always be open to exploring opportunities that fit our strategic vision provided that we carefully consider the risks along with the cash flow returns that drive shareholder value.”


Merv Simchowitz, CEO of Pure Dispensaries, LLC said, “The unwinding of this deal is something that I myself am in full support of as an investor in Orchid. Pure Dispensaries has identified an alternative buyer and we are currently in negotiations. This third party has access to large amounts of capital and can safely pull off the acquisition plus have enough funding to set themselves up for success through the tough, initial phases of a start-up. Corey and I continue to work closely together and I consider myself one of the biggest advocates of Orchid. I feel that with the changing realities of both the cannabis industry and capital markets, Orchid’s sharpened focus on leveraging their strengths to successfully deliver on strategic business objectives will establish them as a high-growth, profitable and valuable company.”

ABOUT ORCHID ESSENTIALS

Orchid Essentials is an Irvine, Calif.-based brand that launched in Oregon and California in August 2017 and has since developed a mass-market brand and loyal consumer following with its premium vape products. Orchid’s product lines are currently sold in 250+ dispensaries across California and Oregon and are handcrafted and designed for maximum flavor and overall enjoyment. The company’s proven processes and passion for what it does carry through into its products. The end result is an unparalleled experience for new and practiced cannabis users alike. Orchid plans to expand its brand into new national markets, as well as global markets such as Latin America and Europe. With a continued focus on brand and intellectual property development, Orchid will execute strategic acquisitions to solidify an integrated cannabis manufacturing and distribution infrastructure with the goal of becoming a dominant premium cannabis brand in the United States. Orchid’s management brings significant branding, product development and distribution experience with a proven track record of scaling revenues, building value-generating partnerships and creating enterprise value. Learn more at https://orchidessentials.com/

ON BEHALF OF THE BOARD of DIRECTORS

Orchid Ventures, Inc.
Corey Mangold,
CEO, Founder & Director
investors@orchidessentials.com
949-357-5818

THE CANADIAN SECURITIES EXCHANGE HAS NOT REVIEWED AND DOES NOT ACCEPT RESPONSIBILITY FOR THE ACCURACY OR ADEQUACY OF THIS RELEASE

Cautionary Statement Regarding “Forward-Looking” Information

This news release contains certain forward-looking information and forward-looking statements within the meaning of applicable securities legislation (collectively “forward-looking statements”). The use of any of the word “will” and similar expressions are intended to identify forward-looking statements. These statements involve known and unknown risks, uncertainties and other factors that may cause actual results or events to differ materially from those anticipated in such forward-looking statements. Such forward-looking statements should not be unduly relied upon.. Actual results achieved may vary from the information provided herein as a result of numerous known and unknown risks and uncertainties and other factors. The Company believes the expectations reflected in those forward-looking statements are reasonable, but no assurance can be given that these expectations will prove to be correct. The Company does not undertake to update these forward-looking statements, except as required by law.

Click here to connect with Orchid Ventures Inc. (CSE:ORCD, OTC:ORVRF) for an Investor Presentation.

Source

 

Cannabis - Will The Fortune 500 Join The Party?

 
Our Exclusive FREE Report Contains Information You NEED To Know About Cannabis Stock Investing!
 

Ayurcann Holdings Corp. (CSE: AYUR) (the “Company” or “Ayurcann”) an integrated Canadian extraction company specializing in the processing of cannabis and hemp for the production of oils and various derivative products, announces the granting of stock options and restricted share units.

The Company has announced that it has granted incentive stock options to directors, officers, employees and consultants of the Company to purchase an aggregate of 1,000,100 common shares under the Company’s Stock Option Plan. Each option is exercisable at a price of $0.16 per common share, expires three years from the date of grant and vest six months from the date of the grant.

Keep reading... Show less

A planned business merger between two leading cannabis producers hit a small delay this week as a critical vote got moved.

Meanwhile, a cannabis retail operator elected to celebrate 420 by auctioning a cannabis-themed digital art piece using blockchain technology.

Keep reading... Show less

Partnerships with Minardi Law , Minorities for Medical Marijuana, CultivatED, and the Georgia Justice Project will include clinics and virtual events across Florida , Georgia , and Massachusetts

Trulieve Cannabis Corp. (CSE: TRUL) (OTCQX: TCNNF) (“Trulieve” or “the Company”), a leading and top-performing cannabis company based in the United States announced today a series of expungment clinics located throughout south and central Florida as well as virtual events in Georgia and Massachusetts . The clinics are part of the Company’s celebration of the 50 th anniversary of 420.

Keep reading... Show less

Seth Rogen’s New Cannabis Brand are Now Available at Apothecarium Dispensaries in San Francisco , Berkeley and Capitola

The Apothecarium is offering cannabis from Houseplant, the cannabis lifestyle brand founded by Seth Rogen and Evan Goldberg at its five California dispensaries. The Apothecarium has three San Francisco locations (Castro, SOMA and Marina ) and one each in Berkeley and Capitola (outside of Santa Cruz ).

Keep reading... Show less